Olshan Represents Pointillist in $12M Financing for Femasys Inc.

Olshan represented Pointillist, the lead investor in a PIPE  with  Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide. Pursuant to the financing,  Femasys  issued an aggregate principal amount of approximately $12 million in senior secured convertible notes and accompanying warrants to purchase shares of common stock for a possible total of $58 million if all warrants are exercised for cash. The proceeds will be used to refinance existing debt and other general corporate purposes. The Olshan team that represented Pointillist included partners Kenneth Schlesinger, Claudia Dubón, Jason Saltsberg, Mary Grieco and Dorothy Sluszka, associate Joshua Park and Branding Paralegal Supervisor Elizabeth Nunn.